NOIDS.wiki
Calculator
Shop Potency Calculator
Cannabis Science

2-AG (2-Arachidonoylglycerol): The Most Abundant Endocannabinoid

Cannabinoid · Endocannabinoid

Non-intoxicatingBody-madeFull CB1/CB2 agonistPreclinical

2-arachidonoylglycerol (2-AG) is the most abundant endocannabinoid in the body, and unlike anandamide, it is a full agonist at both CB1 and CB2 receptors. It is made on demand and broken down by the enzyme MAGL, and it is central to how neurons turn signalling up and down (retrograde signalling).

Full name
2-arachidonoylglycerol
Molecular formula
C23H38O4
Molar mass
378.55 g/mol
Identifier
CAS 53847-30-6
Made by
DAGL, on demand
Broken down by
MAGL
Intoxicating?
No: endogenous signalling

The main endocannabinoid

Full agonist, high abundance

2-AG is present at much higher levels than anandamide and activates CB1/CB2 fully rather than partially. In the brain it is released “backwards” across synapses to quiet incoming signals, a feedback brake on neurotransmission. Blocking MAGL raises 2-AG and is studied for pain and inflammation.1

Frequently Asked Questions

What is the difference between 2-AG and anandamide?

Both are endogenous cannabinoids, but 2-AG is present at roughly 100-fold higher brain concentrations and acts as a full agonist at CB1 and CB2 receptors, whereas anandamide is a lower-abundance partial agonist broken down by FAAH rather than MAGL.

Is 2-AG intoxicating?

No. 2-AG is an endogenous lipid messenger synthesized on demand from membrane phospholipids by diacylglycerol lipase (DAGL) and rapidly hydrolyzed by monoacylglycerol lipase (MAGL) to regulate local synaptic transmission.

Is 2-AG found in the cannabis plant?

No. 2-AG is an endocannabinoid produced inside mammalian tissues, not a phytocannabinoid synthesized by Cannabis sativa trichomes.

Sources

  1. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J., & Vogel, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology, 50(1), 83-90. PubMed 7605349
  2. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995). 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications, 215(1), 89-97. PubMed 7575630
  3. Baggelaar, M. P., Maccarrone, M., & van der Stelt, M. (2018). 2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain. Progress in Lipid Research, 71, 1-17. PubMed 29753749
  4. National Center for Biotechnology Information (NCBI). PubChem Compound Summary for CID 5282280, 2-Arachidonoylglycerol. NCBI PubChem CID 5282280

Part of the NOIDS cannabinoids index. Educational reference, not medical advice.

This article is for educational purposes only. Always follow local laws regarding cannabis preparation and use.

Scroll to Top